X-14912325-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_152581.4(MOSPD2):āc.956C>Gā(p.Pro319Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00013 in 1,172,469 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 56 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00017 ( 0 hom., 8 hem., cov: 23)
Exomes š: 0.00013 ( 0 hom. 48 hem. )
Consequence
MOSPD2
NM_152581.4 missense
NM_152581.4 missense
Scores
2
7
8
Clinical Significance
Conservation
PhyloP100: 6.11
Genes affected
MOSPD2 (HGNC:28381): (motile sperm domain containing 2) Involved in positive regulation of monocyte chemotaxis and positive regulation of neutrophil chemotaxis. Located in endoplasmic reticulum and endoplasmic reticulum-endosome membrane contact site. Is integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.12258494).
BS2
High Hemizygotes in GnomAd4 at 8 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MOSPD2 | NM_152581.4 | c.956C>G | p.Pro319Arg | missense_variant | 10/15 | ENST00000380492.8 | NP_689794.1 | |
MOSPD2 | NM_001330241.2 | c.956C>G | p.Pro319Arg | missense_variant | 10/15 | NP_001317170.1 | ||
MOSPD2 | NM_001177475.2 | c.767C>G | p.Pro256Arg | missense_variant | 9/14 | NP_001170946.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MOSPD2 | ENST00000380492.8 | c.956C>G | p.Pro319Arg | missense_variant | 10/15 | 1 | NM_152581.4 | ENSP00000369860 | P1 | |
MOSPD2 | ENST00000482354.5 | c.956C>G | p.Pro319Arg | missense_variant | 10/15 | 5 | ENSP00000473271 | |||
MOSPD2 | ENST00000460386.1 | c.317C>G | p.Pro106Arg | missense_variant | 3/5 | 5 | ENSP00000473379 | |||
MOSPD2 | ENST00000495110.1 | n.1044C>G | non_coding_transcript_exon_variant | 9/14 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 19AN: 110993Hom.: 0 Cov.: 23 AF XY: 0.000240 AC XY: 8AN XY: 33313
GnomAD3 genomes
AF:
AC:
19
AN:
110993
Hom.:
Cov.:
23
AF XY:
AC XY:
8
AN XY:
33313
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000115 AC: 18AN: 156272Hom.: 0 AF XY: 0.000201 AC XY: 10AN XY: 49638
GnomAD3 exomes
AF:
AC:
18
AN:
156272
Hom.:
AF XY:
AC XY:
10
AN XY:
49638
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000125 AC: 133AN: 1061430Hom.: 0 Cov.: 27 AF XY: 0.000142 AC XY: 48AN XY: 337882
GnomAD4 exome
AF:
AC:
133
AN:
1061430
Hom.:
Cov.:
27
AF XY:
AC XY:
48
AN XY:
337882
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000171 AC: 19AN: 111039Hom.: 0 Cov.: 23 AF XY: 0.000240 AC XY: 8AN XY: 33369
GnomAD4 genome
AF:
AC:
19
AN:
111039
Hom.:
Cov.:
23
AF XY:
AC XY:
8
AN XY:
33369
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
22
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 16, 2023 | The c.956C>G (p.P319R) alteration is located in exon 10 (coding exon 10) of the MOSPD2 gene. This alteration results from a C to G substitution at nucleotide position 956, causing the proline (P) at amino acid position 319 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;.
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;.
REVEL
Benign
Sift
Uncertain
D;.;.
Sift4G
Uncertain
D;T;D
Polyphen
P;.;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at